266 related articles for article (PubMed ID: 2926567)
1. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis.
Sinai-Trieman L; Salusky IB; Fine RN
J Pediatr; 1989 Apr; 114(4 Pt 1):550-4. PubMed ID: 2926567
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
Ongkingco JR; Ruley EJ; Turner ME; Fragale MR
Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis.
Belsha CW; Berry PL
Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362
[TBL] [Abstract][Full Text] [Related]
5. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
Yalçinkaya F; Tümer N; Cakar N; Ozkaya N
Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
[TBL] [Abstract][Full Text] [Related]
6. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
[TBL] [Abstract][Full Text] [Related]
7. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
Zappacosta AR; Perras ST; Bell A
Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
Montini G; Zacchello G; Perfumo F; Edefonti A; Bassi S; Cantaluppi A; Sarchi C; Cazzin M; Ferrari V; Boccazzi A
J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
[TBL] [Abstract][Full Text] [Related]
9. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
Hisano S; Kaku Y; Ueda K; Onoyama K
Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
[TBL] [Abstract][Full Text] [Related]
11. Therapy of renal anemia in children and adolescents with recombinant human erythropoietin (rHuEPO).
Campos A; Garin EH
Clin Pediatr (Phila); 1992 Feb; 31(2):94-9. PubMed ID: 1544282
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.
Shrivastava D; Rao TK; Sinert R; Khurana E; Lundin AP; Friedman EA
Am J Kidney Dis; 1995 Jun; 25(6):904-9. PubMed ID: 7771487
[TBL] [Abstract][Full Text] [Related]
13. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Law CB; Ting SM; Li P; Lai KN
Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial.
Eschbach JW; Abdulhadi MH; Browne JK; Delano BG; Downing MR; Egrie JC; Evans RW; Friedman EA; Graber SE; Haley NR
Ann Intern Med; 1989 Dec; 111(12):992-1000. PubMed ID: 2688507
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
16. Anemia of chronic renal failure: treatment with erythropoietin.
Navarro M; Alonso A; Avilla JM; Espinosa L
Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
Aufricht C; Marik JL; Ettenger RB
Pediatr Nephrol; 1998 Jan; 12(1):10-3. PubMed ID: 9502558
[TBL] [Abstract][Full Text] [Related]
18. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
19. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
Goldraich I; Goldraich N
Adv Perit Dial; 1992; 8():440-3. PubMed ID: 1361843
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]